Home - Products - Others - Other Targets - (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate

(3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate

CAS No. 94753-06-7

(3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate( ——— )

Catalog No. M39133 CAS No. 94753-06-7

(3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 569 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate
  • Description
    (3E,5E,11E)-tridecatriene-7,9-diyne-1,2-diacetate
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    94753-06-7
  • Formula Weight
    286.3
  • Molecular Formula
    C17H18O4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chitinase, Serratia ...

    Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).

  • Carbidine

    Carbidine is an atypical neuroleptic compound.

  • (-)-Epiafzelechin

    (-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.